7.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2026-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
98.78%
0.1665
|
13.68 | 8.2924 | 10.84 | 9.1313 |
| Research and Development |
0.7722
|
- | - | - | - |
| Interest Income/Expense |
99.36%
0.000724
|
0.1129 | 0.1097 | 0.1095 | 0.0858 |
| Costs And Expenses |
77.98%
3.3269
|
15.11 | 10.26 | 11.58 | 12.26 |
| Operating Income/Loss |
130.49%
-3.1605
|
-1.3712 | -1.9653 | -0.7475 | -3.1293 |
| Income/Loss From Continuing Operations Before Tax |
117.01%
-3.1003
|
-1.4286 | -1.9434 | -0.7295 | 1.2539 |
| Income Tax Expense/Benefit |
83.35%
0.00387
|
0.0232 | 0.00567 | 0.00567 | 0.00387 |
| Income/Loss From Continuing Operations After Tax |
117.28%
-3.1042
|
-1.4286 | -1.949 | -0.7352 | 1.2482 |
| Net Income/Loss |
199.20%
-4.2744
|
-1.4286 | -1.949 | -0.7352 | -3.2871 |
| Attributable To Noncontrolling Interest |
111.49%
0.00195
|
-0.017 | -0.00828 | 0.00553 | 0.00259 |
| Basic Average Shares |
15,183%
14.98
|
-0.0993 | 14.96 | 14.96 | 14.96 |
| Diluted Average Shares |
15,183%
14.98
|
-0.0993 | 14.96 | 14.96 | 14.96 |
| Basic Earnings Per Share |
222.22%
-0.29
|
-0.09 | -0.13 | -0.05 | -0.22 |
| Diluted Earnings Per Share |
222.22%
-0.29
|
-0.09 | -0.13 | -0.05 | -0.22 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):